Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT00433381 · COMPLETED
Trial details
- NCT number
- NCT00433381
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2010-01-21
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.